Protective effect of sevoflurane on vascular endothelial glycocalyx in patients undergoing heart valve surgery: A randomised controlled trial
CONCLUSION
Sevoflurane can decrease glycocalyx degradation in patients undergoing heart valve surgery under cardiopulmonary bypass.
TRIAL REGISTRATION
Chinese Clinical Trial Registry, chictr.org.cn, identifier: ChiCTR1800016367.
Source: European Journal of Anaesthesiology - Category: Anesthesiology Tags: Anaesthesia Source Type: research
More News: Anesthesia | Anesthesiology | Cardiology | China Health | Clinical Trials | Diprivan | Heart | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Propofol | Sevoflurane | Study | Ultane